Podravka, the beloved Croatian food and pharma brand, is cooking up big ambitions far beyond the Balkans.
With a freshly unveiled strategy stretching to 2030, the company sets its sights on global growth—Australia among the prime targets.
This expansion is fuelled by three strategic pillars: nutrition, agriculture, and pharmaceuticals.
Backed by a 19.3% jump in Q1 sales and a staggering 219% rise in net profit after minority interest, Podravka is capitalising on strong momentum.
Despite a normalised profit dip, the long-term vision remains robust. Agriculture takes centre stage, with €200m earmarked for tech-driven upgrades, sustainable farming, and pig farm expansion.
Flagship brand Vegeta leads the global food charge, alongside rising stars like Čokolino and Baranjko. Meanwhile, Belupo, Podravka’s pharma arm, aims to become Europe’s dermatology leader by 2030, investing €36m in R&D and greener production.
From rural fields to urban shelves, Podravka’s evolution is a blueprint in balancing local roots with global ambition.
